🎙️ Practica Talks: Inside the $25M Series A of Atrandi Biosciences
​Join us for a special episode of Practica Talks, where we go behind the scenes of Atrandi’s latest $25M Series A round.
In this conversation, Donatas Keras is joined by Juozas Nainys, CEO & Co-founder of Atrandi Biosciences, and David Yang from Lux Capital—the lead investor in this landmark round.
​Together, they unpack:
​✅ What Atrandi is building and why it matters
✅ The investment thesis from Lux Capital’s perspective
âś… Where Atrandi is headed: scientific vision, product roadmap, and long-term impact
✅ The state of AI in biotech: where we really are, and what’s next
âś… Advice for deep tech founders navigating early-stage growth
From the lab to the boardroom, this is an unfiltered look at how breakthrough companies get built—and funded.
​Tune in!